Insider Trading1 Sept 2026, 03:43 pm
Symbiotec Pharmalab Ltd: Disclosure on Insider Trading Code
AI Summary
Symbiotec Pharmalab Ltd has filed an intimation under Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company has enclosed its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information, framed under Regulation 8(1) of the SEBI PIT Regulations. This disclosure is for informational purposes and to ensure compliance with regulatory requirements regarding the handling of sensitive company information.
Key Highlights
- Company complies with SEBI PIT Regulations.
- Code for Fair Disclosure of UPSI enclosed.
- Ensures transparency in information dissemination.
- Regulatory compliance is maintained.
Price Impact
More from SYMBIOTEC